Position Overview
The Beth Israel Lahey Health (BILH), Joslin Diabetes Center is seeking applications for the position of President and Chief Scientific Officer . An academic appointment as Full or Associate Professor in the Field of Diabetes at Harvard Medical School (HMS) will be commensurate with experience, training, and achievements in addition to teaching activities.
Joslin Diabetes Center is world-renowned for its expertise in diabetes treatment and research. As one of only 18 NIH‑designated Diabetes Research Centers in the United States serving more than 20,000 adults and children each year, Joslin sets the standard for diabetes care through highly specialized treatment, education, and clinical models recognized worldwide. The center’s team of nationally certified diabetes educators—including nurses, dietitians, and exercise physiologists—provides the highest quality care and education for patients.
Responsibilities
The President & Chief Scientific Officer will serve as a visionary leader responsible for defining and advancing the scientific and strategic direction of Joslin Diabetes Center. This individual will oversee all core departments—Research, Clinical Services, Fiscal Services, Philanthropy, Commercial Ventures, and Quality—ensuring integration with BILH while maintaining Joslin’s identity as an independent center of excellence. In close collaboration with BILH leadership, the Joslin Board of Trustees, and Harvard Medical School, the President & Chief Scientific Officer will align research, clinical, and educational missions to drive innovation, sustainability, and impact in diabetes care and discovery.
Qualifications
Applicants should be nationally or internationally recognized leaders in academic medicine or diabetes research with a proven track record of scientific achievement, programmatic leadership, and team development. They must demonstrate a vision for advancing academic accomplishment and possess leadership skills to nurture and enhance the research, teaching, and clinical portfolios of an outstanding Field of Diabetes. Members of the HMS‑wide Diabetes Executive Committee will collaborate academically with other HMS teaching hospitals, so exemplary administrative, operational, financial, academic mentoring, and communication acumen are required. The ideal candidate will inspire collaboration, drive innovation, and advance Joslin’s global reputation as a pioneer in diabetes treatment and research.
Contact Information
Committee Chair : Mark Zeidel, MD
Chair, Department of Medicine and Physician in Chief, BIDMC
Herrman L. Blumgart Professor of Medicine, HMS
mzeidel@bidmc.harvard.edu
Prospective applicants should apply directly to the Workday posting. For any questions, please direct them to the contact information above.
Salary
The pay range for this position is $350,000–$540,000, which is the annual base salary range the organization reasonably and in good faith expects to pay for this position at this time. In addition to base compensation, this position may be eligible for additional compensation, which may include performance‑based incentive bonuses.
Equal Employment Opportunity
We are an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability status, protected veteran status, gender identity, sexual orientation, pregnancy and pregnancy‑related conditions or any other characteristic protected by law.
#J-18808-Ljbffr
Chief Scientific Officer • Boston, MA, United States